Tobramycin

Tobramycin is a amino cyclitol glycoside that is kanamycin B lacking the 3-hydroxy substituent from the 2,6-diaminoglucose ring. Among its listed roles, it functions as a antibacterial agent, an antimicrobial agent and a toxin. Functionally, it is related to kanamycin B. It is the conjugate base of tobramycin. It is grouped under the following drug class(es): Aminoglycosides. Its therapeutic use is listed as anti-infectives, antibacterials, antibiotics and ophthalmic agents. The directory classifies it as a commercial API with a fermentation-derived source/manufacturing origin. Other names for this substance include Nebramycin VI, Nebramycin 6, Obramycin, Bethkis and Kitabis Pak. Its PubChem CID is 36294.

CAS No 32986-56-4
Molecular Formula C18H37N5O9
Molecular Weight 467.5 g/mol
Synonyms (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol

Frequently Asked Questions